Abstract:Spatiotemporal patterns of gene expression depend on enhancer elements and other factors during individual development and disease progression. The rapid progress of high-throughput techniques has led to well-defined enhancer chromatin properties. Various genome-wide methods have revealed a large number of enhancers and the discovery of three-dimensional (3D) genome architecture showing the distant interacting mechanisms of enhancers that loop to target gene promoters. Whole genome sequencing projects directed at cancer have led to the discovery of substantial enhancer dysfunction in misregulating gene expression and in tumor initiation and progression. Results from genome-wide association studies (GWAS) combined with functional genomics analyses have elucidated the functional impacts of many cancer risk-associated variants that are enriched within the enhancer regions of chromatin. Risk variants dysregulate the expression of enhancer variant-associated genes via 3D genomic interactions. Moreover, these enhancer variants often alter the chromatin binding affinity for cancer-relevant transcription factors, which in turn leads to aberrant expression of the genes associated with cancer susceptibility. In this review, we investigate the extent to which these genetic regulatory circuits affect cancer predisposition and how the recent development of genome-editing methods have enabled the determination of the impacts of genomic variation and alteration on cancer phenotype, which will eventually lead to better management plans and treatment responses to human cancer in the clinic.

Engineering 3D genome organization

Exploring the mechanisms of genome-wide long-range interactions: interpreting chromosome organization.

3D Genome and Its Disorganization in Diseases

Regulation of 3D Organization and Its Role in Cancer Biology

3D Genomic Organization in Cancers

Gene Regulation in the 3D Genome.

CRISPR Double Cutting Through the Labyrinthine Architecture of 3D Genomes

Enhancer Dysfunction in 3D Genome and Disease

The 3D Genome and Its Impacts on Human Health and Disease

Three-dimensional genome architecture and emerging technologies: looping in disease

Probing 3D genome by CRISPR/Cas9

3D chromatin architecture and transcription regulation in cancer

The advances in CRISPR technology and 3D genome

Understanding Regulatory Mechanisms of Brain Function and Disease Through 3D Genome Organization

[Advances in three-dimensional genomics]

3D Genome Organization in the Central Nervous System, Implications for Neuropsychological Disorders

The role of 3D genome organization in development and cell differentiation

Disorder of Three‐dimensional Chromosome Structure Plays a Role in Carcinogenesis

3D genome organization and epigenetic regulation in autoimmune diseases

A tour of 3D genome with a focus on CTCF

Application of Hi-C technology in three-dimensional genomics research and disease pathogenesis analysis.